Announced
Synopsis
Taimei Technology, a Chinese cloud-based software provider that serves pharmaceutical companies and clinical research organizations, completed Series E and Series E+ rounds of financing at $212m. Taimei Technology operates as a technology solution provider in the field of life sciences with a focus on clinical research and pharmacovigilance, which is also known as drug safety, is related to the collection, detection, assessment, monitoring, and prevention of adverse effects of pharmaceutical products.
Show Details & Financials
Sort
Search a database of more than 250,000 verified dealmakers
Receive automated updates on global transactions
Follow the activity, relationships and transactions of top dealmakers
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.